Miguel Paja1,2, Jose L del Cura3,4, Rosa Zabala5, Igone Corta5, Aitzol Lizarraga1, Amelia Oleaga1, Amaia Expósito6, M Teresa Gutiérrez6, Aitziber Ugalde7, José I López8,2. 1. Department of Endocrinology, Basurto University Hospital, Bilbao, Spain. 2. Basque Country University, Bilbao, Spain. 3. Department of Radiology, Basurto University Hospital, Bilbao, Spain. jlcura@euskalnet.net. 4. Basque Country University, Bilbao, Spain. jlcura@euskalnet.net. 5. Department of Radiology, Basurto University Hospital, Bilbao, Spain. 6. Department of Endocrine Surgery, Basurto University Hospital, Bilbao, Spain. 7. Department of Pathology, Basurto University Hospital, Bilbao, Spain. 8. Department of Pathology, Cruces University Hospital, Barakaldo, Spain.
Abstract
OBJECTIVES: To analyze the diagnostic accuracy of ultrasound-guided core-needle biopsy (CNB) of thyroid nodules. METHODS: Of 3517 CNBs performed using an 18G spring-loaded device in one institution, we retrospectively reviewed 676 nodules in 629 consecutive patients who underwent surgery. CNB and pathological examination were compared. CNB diagnosis was standardized in four categories: insufficient (I), benign (B), follicular lesion (FOL), and malignant (M). Main outcome measures were predictive positive values (PPV), false positives (FP), and false negatives (FN). RESULTS: CNB showed a low rate of insufficient and FOL diagnoses (5.8 % and 4.5 %). On surgery, there were eight FNs in 374 benign CNBs and three FPs in 148 malignant CNBs. The 154 nodules classified as FOL in CNB included, at surgery, 122 neoplasms; 28 of them malignant. PPV for malignancy of a malignant CNB was 98 %, and for a CNB diagnosis of FOL 18.2 %. Sensitivity for malignancy if CNB of FOL and M are considered positive was 95.6. Only one major complication was observed. CONCLUSIONS: CNB is reliable, safe, and accurate to evaluate thyroid nodules and can be an alternative technique to FNA. It has low rate of non-diagnostic and undetermined cases, with high sensitivity and PPV. KEY POINTS: Thyroid core-needle biopsy (CNB) has high sensitivity and PPV. Pitfalls of CNB are rare. Pitfalls are due to cystic cancer, histological heterogeneity, and mistakes in analysis. CNB is a reliable, safe, and accurate method to approach thyroid nodules. CNB can be used primarily or after insufficient or indeterminate FNA.
OBJECTIVES: To analyze the diagnostic accuracy of ultrasound-guided core-needle biopsy (CNB) of thyroid nodules. METHODS: Of 3517 CNBs performed using an 18G spring-loaded device in one institution, we retrospectively reviewed 676 nodules in 629 consecutive patients who underwent surgery. CNB and pathological examination were compared. CNB diagnosis was standardized in four categories: insufficient (I), benign (B), follicular lesion (FOL), and malignant (M). Main outcome measures were predictive positive values (PPV), false positives (FP), and false negatives (FN). RESULTS: CNB showed a low rate of insufficient and FOL diagnoses (5.8 % and 4.5 %). On surgery, there were eight FNs in 374 benign CNBs and three FPs in 148 malignant CNBs. The 154 nodules classified as FOL in CNB included, at surgery, 122 neoplasms; 28 of them malignant. PPV for malignancy of a malignant CNB was 98 %, and for a CNB diagnosis of FOL 18.2 %. Sensitivity for malignancy if CNB of FOL and M are considered positive was 95.6. Only one major complication was observed. CONCLUSIONS: CNB is reliable, safe, and accurate to evaluate thyroid nodules and can be an alternative technique to FNA. It has low rate of non-diagnostic and undetermined cases, with high sensitivity and PPV. KEY POINTS: Thyroid core-needle biopsy (CNB) has high sensitivity and PPV. Pitfalls of CNB are rare. Pitfalls are due to cystic cancer, histological heterogeneity, and mistakes in analysis. CNB is a reliable, safe, and accurate method to approach thyroid nodules. CNB can be used primarily or after insufficient or indeterminate FNA.
Authors: Mitchell E Tublin; Joseph A Martin; Lori J Rollin; Karen Pealer; Marcia Kurs-Lasky; N Paul Ohori Journal: J Ultrasound Med Date: 2007-12 Impact factor: 2.153
Authors: David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle Journal: Thyroid Date: 2009-11 Impact factor: 6.568
Authors: Jason D Oppenheimer; Deepa Kasuganti; Ritu Nayar; Howard B Chrisman; Robert J Lewandowski; Albert A Nemcek; Robert K Ryu Journal: Cardiovasc Intervent Radiol Date: 2009-11-24 Impact factor: 2.740
Authors: Sang Hyun Choi; Jung Hwan Baek; Jeong Hyun Lee; Young Jun Choi; Min Ji Hong; Dong Eun Song; Jae Kyun Kim; Jong Ho Yoon; Won Bae Kim Journal: Eur Radiol Date: 2014-07-20 Impact factor: 5.315
Authors: E Aysan; T Kiran; U O Idiz; B Guler; H Akbulut; E Kunduz; S Arici; G Kadakal; M Ozgor; K Coci Journal: Ann R Coll Surg Engl Date: 2016-10-28 Impact factor: 1.891